Regulatory Filings

Regulatory Filings

• Board Decisions – 6th November 2024
• Board Decisions – 13th August 2024
• Investor Call Invite – 14th August 2024
• Outcome of the Board Meeting – 30th May 2024
• Transcript – Investor Call – 27th April 2024
• Audio Recordings of Investors Call – 27th April 2024
• Outcome of the Board Meeting- 26th April 2024
• Investor Call Invite (revised) – 27th April 2024
• Investor Call Invite – 27th April 2024
• Investor Presentation – 26th April 2024
• Reg 30 Disclosure – intimation of changes in senior management personnel – 19th March 2024
• Investor Presentation – 8th February 2024
• Press Release – 8th February 2024
• Intimation of consideration of Interim Dividend
• Board Decisions – 08th Feb 2024
• compliance under Reg 52_54
• Investors Concall Invite Revised – 24th Jan 2024 – 3rd February 2024
• Investors Concall Invite – 24th January 2024
• Notice of Board Meeting – 17th January 2024
• Reg_57(1)_Disclosure – 12th January 2024
• Statement under Reg 13(3) for the quarter ended 31st December 2023
• Reg 30 Disclosure_Intimation of change in shareholding in AHHL – 27th December 2023
• Intimation of Trading Window – 22nd December 2023
• Specification_Debt_ISIN_Details – 16th November 2023
• Compliance under 52_54 – 9th November 2023
• Statement under Regulation 13(3) for the quarter ended 30th September 2023
• Notice of Record date
• Active ISIN-30th September 2023
• Investor Presentation – 9th November 2023
• Board Decisions – 9th November 2023
• Investor Concall Invite – 3rd November 2023
• Credit Rating Letter – 28th October 2023
• Notice of the Board Meeting – 28th October 2023
• Press Release – Kolkata – 27th September 2023
• Intimation Trading Window – 26th September 2023
• Reg 30 disclosure – Appointment of Senior Management Personnel 19th September 2023
• Voting Results – AGM 30th August 2023
• Investor Presentation – 11th August 2023
• Board Decisions 11th August 2023
• Investors Concall Invite – 9th August 2023
• Notice of Board Meeting – 17th July 2023
• compliance under Reg57(5) 3rd July 2023
• Statement under Regulation 13(3) for the quarter ended 30th June 2023
• caption Intimation of Trading Window_June 2023
• compliance under Reg57(4) 21st June 2023
• Intimation reg.change in AGM Date – 2nd June 2023
• Outcome Analyst Call – 31st May 2023
• Compliance Under 52_54 – 30th May 2023
• Investor Presentation – 30th May 2023
• Press Release – 30th May 2023
• Investors call invite 25th May 2023
• compliance under Reg57(4) 21st Mar 2023
• Half Yearly Disclosures on RPT 31st March 2023
• Statement under Regulation 13(3) for the quarter ended 31st Mar 2023
• Intimation Trading Window – 27th Mar 2023
• Secretarial Compliance Report – March 2023
• compliance under Reg 57(5) March 2023
• Annual Disclosure Large Entity March 2023
• Board Decisions 30th May 2023
• Notice of Board Meeting 8th May 2023
• record date revised intimation 16th Feb 2023
• Board Decisions – 14th February 2023
• compliance under 52_54 – 14th Feb 2023
• Investor Presentation – 14th Feb 2023
• Notice of Board Meeting – 31st Jan 2023
• compliance under Reg57(1) 12th Jan 2023
• Statement under Regulation 13(3) for the quarter ended 31st Dec 2022
• Intimation Trading Window – 26th Dec 2022
• compliance under Reg57(4) 24th Dec 2022
• Notice of Record Date 20th Dec 2022
• Allotment of NCDs 14th Dec 2022
• Notice of Unsecured Debentures 6th Dec 2022
• Reg 30 disclosure – Letter of comfort – 6th Dec 2022
• Board Decisions – 30th November 2022
• Notice of the Board Meeting 26th November 2022
• Half Yearly Disclosures on RPT 30th September 2022
• Investor Presentation – 12th November 2022
• Investors call invite 11th Nov 2022
• Board Decisions – 10th November 2022
• Investor Call Invite – 31st October 2022
• Notice of the Board Meeting 14th October 2022
• Statement under Regulation 13(3) for the quarter ended 30th Sept 2022
• Intimation Acquisition of AyurVaid Hospitals
• Intimation Trading Window – 29th September 2022
• Voting Results – AGM 25th August 2022
• Investor Presentation – 12th August 2022
• Board Decisions – 11th August 2022
• Investor Call Invite – 9th August 2022
• Acquisition of 650 bed hsopital facility Gurgaon 8th August 2022
• Notice of the Board Meeting 26th July 2022
• Board Decisions – 16th July 2022
• Statement under Regulation 13(3) for the quarter ended 30th June 2022
• Intimation Trading Window – 27th June 2022
• Investor Presentation – 26th May 2022
• Board Decisions – 25th May 2022
• Investor Call Invite – 23rd May 2022
• Annual Disclosure – Large Entity- 14th May 2022
• Initial Disclosure – Large Entity – 29th April 2022
• Notice of the Board Meeting 25th April 2022
• Statement under Regulation 13(3) for the quarter ended 31st March 2022
• Half Yearly Disclosures on RPT 31st March 2022
• Intimation Trading Window – 26th March 2022
• Intimation effective date transfer of undertaking 16th March 2022
• Intimation-Regulation 57(1) NCD payment 8th Mar 2022
• Regulation 52(7) 14th Feb 2022
• Investor Presentation 12th Feb 2022
• Board Decisions – 11th February 2022
• Investors call invite 10th Feb 2022
• Investor Call Invite – 8th Feb 2022
• Intimation Record NCD 5th Feb 2022
• Investor Call Invite – 4th Feb 2022
• Intimation credit rating 31st Jan 2022
• Investors call invite 28th Jan 2022
• Intimation upcoming launch amazon 28th Jan 2022
• Notice of the Board Meeting 24th Jan 2022
• Statement under Regulation 13(3) for the quarter ended 31st December 2021
• Intimation of Closure of Trading Window 22nd Dec 2021
• Voting Results Director appointment 21st Dec 2021
• Notice of Postal Ballot 18th November 2021
• Investor Presentation 13th November 2021
• Board Decisions – 12th November 2021
• Investors call invite 10th November 2021
• Notice of the Board Meeting 25th Oct 2021
• Statement under Regulation 13(3) for the quarter ended 30th September 2021
• Half Yearly disclosures RPT 30th Sept 2021
• Intimation of Closure of Trading Window 30th Sep 2021
• Voting Results – AGM – 31st August 2021
• Voting Results slumpsale backendpharmacy 14th August 2021
• Investor Presentation 13th August 2021
• Board Decisions – 13th August 2021
• Investors call invite 12th August 2021
• Notice of the Board Meeting 03rd August 2021
• Board Decisions 21st July 2021
• Notice of Postal Ballot 13th July 2021
• QIP-PPD Jan 2021
• Pharmacy Restructuring
• Execution of BTA – 1st July 2021
• Intimation of Closure of Trading Window – 30th June 2021
• Confirmation of order of Scheme of Amalgamation – 30th June 2021
• Statement under Regulation 13(3) for the quarter ended 30th June 2021
• Certificate under Regulation 52(5) 28th June 2021
• Certificate compliance 57(2) 24th June 2021
• Investor call invite presentation 23rd June 2021
• Board Decisions – 23rd June 2021
• Notice of the Board Meeting – 08th June 2021
• Annual Disclosure – Large Entity – 15th May 2021
• Voting Results – merger – 4th May 2021
• Initial Disclosure – Large Entity – 30th April 2021
• Notice of acquisition – 22nd April 2021
• Half Yearly Disclosures on RPT 31st March 2021
• Statement under Regulation 13(3) for the quarter ended 31st March 2021
• Notice of Postal Ballot – 31st March 2021
• Intimation of Closure of Trading Window – 29th March 2021
• Board Decisions – 27th March 2021
• Intimation of Record Date – 8th February 2021
• Intimation – Scheme of Amalgamation – 28th January 2021
• Notice of the Board Meeting – 28th January 2021
• Committee Decisions – 23rd January 2021
• Committee Decisions – 22nd January 2021
• Board Decisions – 18th January 2021
• Notice of the Committee Meeting – 18th January 2021
• Intimation of Notice of investor meetings – 11th January 2021
• Intimation of Notice of investor meetings – 6th January 2021
• Statement under Regulation 13(3) for the quarter ended 31 December 2020
• Board Decisions – 2nd December 2020
• Intimation of Closure of Trading Window – December 2020
• Notice – 7th December 2020
• Notice of the Board Meeting – 7th November 2020
• Notice of the Board Meeting – 2nd November 2020
• Half Yearly Disclosures on RPT-30th September 2020
• Statement under Regulation 13(3) for the quarter ended 30th September 2020
• Board Decisions – December 2020
• Voting Results QIP 2020
• Board Decision – November 2020
• Intimation of Closure of Trading Window – September 2020
• Voting Results 2020
• Board Decision – September 2020
• Half Yearly Disclosure on Related Party Transactions – 31st March 2020
• Intimation of sanction of Scheme of Arrangement by NCLT
• Notice for Board Meeting
• Intimation of effective date of Scheme of Arrangement
• Call Option Notice – NCDs
• Intimation Record Date – NCDs
• Statement under Regulation 13(3) for the quarter ended 30th June 2020
• Intimation of Closure of Trading Window – June 2020
• Board Decisions – June 2020
• Notice of Board Meeting – Revised Date
• Notice of Board Meeting
• Intimation of Closure of Trading Window
• Statement under Regulation 13(3) for the quarter ended 31st March 2020
• Notice for Board Meeting
• Notice for Board Meeting
• Statement under Regulation 13(3) for the quarter ended 31st December 2019
• Statement under Regulation 13(3) for the quarter ended 30th September 2019
• Statement under Regulation 13(3) for the quarter ended 30th June 2019
• Board Decisions – February 2020
• Half Yearly Disclosure on Related Party Transactions – 30th September 2019
• Board Decisions – November 2019
• Board Decisions – August 2019
• Half Yearly Disclosure on Related Party Transactions – 31st March 2019
• Notice for Board Meeting
• Intimation to Stock Exchange – Apollo Munich Health Insurance Company Limited
• Complaint Report NSE
• Complaint Report BSE
• Financial Results – March 2019
• Notice for Board Meeting
• Intimation of Record Date – NCD-7104, Aug 2018
• Intimation of Record Date – NCD-7104, Jul 2018
• Intimation of Record Date – NCD 7112
• Intimation of Record Date – NCD 7120
• Notice of Board Meeting – August 2018
• Notice of Board Meeting – February 2019
• Notice of Board Meeting – May 2018
• Notice of Board Meeting – November 2018
• Intimation to Stock Exchange – Change in Directors
• Intimation regarding Scheme of Arrangement – AHEL and Apollo Pharmacies Limited
• Board Decisions – February 2019
• Board Decisions – November 2018
• Intimation regarding resignation of 2 Independent Directors
• Voting Results 2017
• Intimation of interest payment of NCDs
• Notice of Board Meeting – November 2016
• Financial Results – November 2016
• Intimation of Record date for Non convertible Debentures
• Notice of Board Meeting – January 2017
• Disclosure under Regulation 30
• Intimation of Record Date of NCDs – Rs. 50 crores
• Intimation of Record Date of NCDs – Rs. 94 crores
• Intimation of Interest payment
• Disclosure under Regulation 30(1) & 30(2) of SEBI SAST
• Notice of Board Meeting – May 2017
• Intimation of unaudited Financial Results – Q1, FY 2017
• AGM Proceeding Voting Results 2016
• Certificate under Regulation 52 (5) of SEBI
• Compliance under Regulation 57 (2) of SEBI
• Letters to stock exchanges
• Audited Financial Results – FY 2016
• Notice for Board Meeting
• Reconciliation of share capital audit report for the quarter ended 31st March 2016
• Certificate under Regulation 40(9)
• Investor complaints statement as on 31st March 2016
• Disclosure under Regulation 30(1) of SEBI LODR
• Disclosure under Regulation 31
• Payment Letter
• Disclosure SE Letters
• Disclosure
• Dividend Communication
• Intimation of Record Date
• Stock Communication
• Notice of Board Meeting
• NCD Interest Intimation
• Half year communication